TWST - Company ID 0001581280
The table below shows Twist Bioscience Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $376.57M | $312.97M | $245.11M | $203.56M | $132.33M | $90.10M |
| Cost of revenue | $185.57M | $179.63M | $155.38M | $119.33M | $80.62M | $61.41M |
| Gross profit | - | - | - | - | - | - |
| R&D | $80.28M | $90.85M | $106.89M | $120.31M | $69.07M | $43.01M |
Twist Bioscience Corp reported annual revenue of $376.57M for fiscal year 2025. That is up 20.3% from $312.97M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $10.77M (FY 2017) to $376.57M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $246.98M |
| $218.40M |
| $189.74M |
| $212.95M |
| $135.90M |
| $103.27M |
| Operating income | -$136.26M | -$220.83M | -$217.16M | -$234.78M | -$152.73M | -$140.08M |
| Income tax | $719.00K | $560.00K | $1.15M | -$10.41M | -$1.93M | $382.00K |
| Net income | -$77.67M | -$208.73M | -$204.62M | -$217.86M | -$152.10M | -$139.93M |
| EPS (diluted) | -$1.30 | -$3.60 | -$3.60 | -$4.04 | -$3.15 | -$3.57 |